The Mesothelioma Center News
New Immunotherapy Clinical Trial Targets Common Mesothelioma Protein
- by Tim Povtak
- Research & Clinical Trials
- Feb 19, 2019
A biotechnology company specializing in innovative cancer therapeutics has opened a clinical trial examining an immunotherapy drug targeting a protein found in 90 percent of malignant mesothelioma tumors. It…
Read More
Dr. Mags Portman, HIV Prevention Pioneer, Dies from Mesothelioma at 44
- by Tim Povtak
- Celebrities
- Feb 14, 2019
Dr. Mags Portman, a British trailblazer in the fight to prevent and control HIV, died Wednesday after a two-year battle with mesothelioma. She was 44. Portman was lauded for…
Read More
J&J Talc Supplier Imerys Files for Bankruptcy Over Cancer Lawsuits
- by Tim Povtak
- Legislation & Litigation
- Feb 14, 2019
Seeking protection from rapidly mounting litigation, Imerys Talc America and two of its subsidiaries filed for Chapter 11 bankruptcy protection Wednesday in Delaware. Imerys is a major talc supplier for…
Read More
Chemo-Carrying Gold Nanoparticles Tested on Mesothelioma
- by Daniel King
- Research & Clinical Trials
- Feb 12, 2019
Italian researchers have found early success using gold nanoparticles as a chemotherapy-delivery vehicle for mesothelioma. They are hopeful their discovery will lead to an improvement in mesothelioma…
Read More
Mesothelioma Immunotherapy Combination Gaining Momentum
- by Tim Povtak
- Research & Clinical Trials
- Feb 11, 2019
Recent studies from France and the Netherlands have shown patients with pleural mesothelioma can benefit significantly from a second-line immunotherapy drug combination. In separate phase II studies, the combination of…
Read More
State Attorneys General Push for Tougher Asbestos Reporting Rule
- by Tim Povtak
- Legislation & Litigation
- Feb 6, 2019
A coalition of 15 attorneys general are calling for a tougher asbestos reporting rule as part of the recently-revised Toxic Substances Control Act. Maine’s newly elected Attorney General Aaron Frey…
Read More
Senator Probing Johnson & Johnson About Asbestos in Talc
- by Tim Povtak
- Legislation & Litigation
- Feb 4, 2019
Sen. Patty Murray, D-Wash., has questions, and she wants answers from Johnson & Johnson about its iconic baby powder and the reported link to asbestos-related cancers. Murray recently sent a…
Read More
Apatinib Case Study Uncovers Potential Mesothelioma Treatment
- by Tim Povtak
- Treatment & Doctors
- Jan 31, 2019
Doctors in China may have uncovered an effective second- or third-line treatment option for patients with malignant pleural mesothelioma. Dr. RongQin Meng, an oncologist at 363 Hospital in Cheng Du,…
Read More
Gene-Editing Tool Reverses Cancer Resistance to Chemotherapy
- by Suzanne Dixon
- Treatment & Doctors
- Jan 28, 2019
A team of researchers at the Gene Editing Institute in Newark, Delaware, has successfully treated chemotherapy-resistant lung cancer cells with the CRISPR gene-editing technique. The study was published Dec. 21,…
Read More
Vaccine and Chemotherapy Combo Shows Promise for Mesothelioma
- by Tim Povtak
- Research & Clinical Trials
- Jan 22, 2019
Mesothelioma patients showed an impressive immune response to TroVax, a novel cancer vaccine, when it was combined with standard chemotherapy in a recent clinical trial. Researchers from Cardiff University in…
Read More
